Head-to-Head: Impax Laboratories VS. SCYNEXIS
Impax Laboratories (NASDAQ:$IPXL) and SCYNEXIS (NASDAQ:$SCYX) are both small-cap companies competing in the medical sector. So how do these two rivals stack up against each other? Let’s look at the numbers. Profitability Impax Laboratories has ... [Read]
Is Impax Laboratories a Buy At $16?
Impax Laboratories (NASDAQ:$IPXL) currently has a going rate of $20.75 per share. This could be a shaky proposition for some investors. However, there may be another way to get in on the drug manufacturer’s stock. ... [Read]
Impax Laboratories Inc: A Technical Snapshot
In the most recent session, shares of Impax Laboratories Inc. (NASDAQ:$IPXL) dropped -$0.83, a volatility of -3.87%. Prices recently reached $20.62 on a volume of 3,190,000. Some investors may value creating innovative and individual strategies ... [Read]
An Analysis of pSivida Corp.
Recently, pSivida Corp. (NASDAQ:$PSDV) has failed to live up to its previous stock prices. The current price stands -1.41% below the 20 day average. While the stock did recover partially over the 50 day moving ... [Read]
Cantor Fitzgerald Restates Impax Laboratories’ ‘Buy’ Rating
On Monday, research analysts Cantor Fitzgerald restated a ‘Buy’ rating for Impax Laboratories, Inc. (NASDAQ:$IPXL). Cantor Fitzgerald also set a price target of $25.00, indicating a potential 8.70% from the stock’s current position. The rating ... [Read]
Impax Laboratories in Talks About Merger with Amneal Pharmaceuticals LLC
The Wall Street Journal has reported Thursday that generic drugmaker Impax Laboratories (NASDAQ:$IPXL) has entered talks with Amneal Pharmaceuticals (Privately Traded) about a possible merger. IPXL is a pharmaceutical company specializing in developing, manufacturing and ... [Read]
Adamas Pharmaceuticals’ Stock Skyrockets After its Drug Gocovri Gain FDA Approval
Drug manufacturer and research company Adamas Pharmaceuticals (NASDAQ:$ADMS) saw its shares rise on Friday, August 25th. The rise can largely be attributed to the fact that the U.S. Food and Drug Administration (FDA) granted approval ... [Read]
Horizon Pharma Increased More Than 13% Today, Here’s Why
On August 17, shares of Horizon Pharma (NASDAQ:$HZNP) increased more than 13%. It all started after the law firm of Green, Griffith & Borg-Breen asserted one of the company’s patents covering Pennsaid 2% against a ... [Read]
Shares of Synergy Pharmaceuticals are Falling Today and This is Why
On August 10, Synergy Pharmaceuticals (NASDAQ:$SGYP) shares dropped as much as 13% in early morning trade. Why? The commercial-stage biopharmaceutical company reported a much higher loss than what Wall Street was expecting. Even though Synergy ... [Read]
Shares Slide After Endo International Lowers 2017 Revenue Forecast
Endo International PLC (NASDAQ:$ENDP) made the decision to lower its 2017 revenue forecast on Tuesday, August 8. The Malvern, Pennsylvania-based company said that it expects lower sales of branded drugs to add to the pricing ... [Read]